Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2006-12-05
2006-12-05
Devi, S. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S234100, C424S190100, C424S184100, C424S203100, C514S002600, C530S350000, C530S825000
Reexamination Certificate
active
07144580
ABSTRACT:
Vaccines and methods againstM. haemolyticainfections in cattle. The vaccine compositions include a recombinant outer membrane protein ofM. haemolyticadesignated PlpE and/or subunits thereof, alone or in combination with other antigenic components, and a carrier or diluent. The methods involve administering an effective immunizing amount of the vaccines to susceptible bovine.
REFERENCES:
patent: 5554372 (1996-09-01), Hunter
patent: 2004/0033234 (2004-02-01), Berinstein et al.
patent: WO 2004/041182 (2004-05-01), None
Pandher, Karamjeet, Confer Anthony W., and Murphy, George L., “Genetic and Immunologic Analyses of PlpE, a Lipoprotein Important in Complement-Mediated Killing ofPasteurella haemolyticaSerotype 1.” Infection and Immunity, Dec. 1998, vol. 66, No. 12, p. 5613-5619.
Morton, DVM, PhD, Rebecaa J., Panciera, DVM, PhD, Roger J., Fulton, DVM, PhD, Robert W., Frank, DVM, PhD, Glynn H., Ewing, DVM, PhD, Sidney A., Homer, PhD, John T., Confer, DVM, PhD, Anthony W., “Vaccination of cattle with outer membrane protein-enriched fractions ofPasteurella haemolyticaand resistance against experimental challenge exposure.”Am J Vet Res,vol. 56, No. 7, Jul. 1995, pp. 875-879.
Pandher, Karamjeet, Murphy, George L., Confer, Anthony W., “Identification of immunogenic, surface-exposed outer membrane proteins ofPasteurella haemolyticaserotype 1.”Veterinary Microbiology65 (1999) pp. 215-226.
PCT International Search Report issued in connection with PCT/US03/34574, date of Mailing Jun. 18, 2004.
Confer, Anthony W., Ayalew, Sahlu, Panciera, Roger J., Montelongo, Marie, Whitworth, Lisa C., Hammer, Jordan D., “Immunogenicity of recombinantMannheimia haemolyticaserotype 1 outer membrane protein PlpE and augmentation of a commercial vaccine.”Vaccine21 (2003) pp. 2821-2829 (publishedafterpriority date).
Ayalew Sahlu
Confer Anthony W.
Murphy George L.
Pandher Karamjeet
Devi S.
Fellers, Snider, Blankenship, Bailey & Tippens
The Board of Regents for Oklahoma State University
LandOfFree
M. haemolytica outer membrane protein P1pE as a vaccine or... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with M. haemolytica outer membrane protein P1pE as a vaccine or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and M. haemolytica outer membrane protein P1pE as a vaccine or... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3685117